Future research opportunities: Knowledge of the effects (or potential effects) of epidemiology, smoking status and diabetes diagnosis on the prevalence of PD-1 inhibitor-associated neuropathy will allow patients to make informed decisions regarding their treatment choices. The gene discussed is PDCD1; the disease is diabetes mellitus.